Lisa Delfini

Lisa Delfini appears in our data through filings on Trevi Therapeutics, Inc. shares, published by SEC (Form 4). We count 22 filings; the first trade dates from 13 February 2023 and the latest from 8 January 2025.

No open-market purchase appears, only 10 sales worth €42k. The rest of the record consists of 12 option exercises.

The latest filing, published on 10 January 2025, reports an option exercise of €2,470 in Trevi Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.